Pfizer CFO Dave Denton to Depart in August for New Industry Role
PFE is trading near its 52-week low of $23.11 (10% above the low).
Summary
Pfizer's Chief Financial Officer, Dave Denton, will leave the company on August 15th to pursue another opportunity in the consumer-goods industry. Denton joined Pfizer in May 2022. Cecile Guegan, Senior Vice President of finance for its global biopharmaceutical business, will serve as interim CFO. The departure of a key executive like the CFO introduces a period of leadership transition and potential uncertainty for a company of Pfizer's size. The company plans an internal and external search for a permanent replacement.
At the time of this announcement, PFE was trading at $25.49 on NYSE in the Life Sciences sector, with a market capitalization of approximately $147.7B. The 52-week trading range was $23.11 to $28.75. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.